Replies to post #23076 on Rich Pharmaceuticals Inc. (fka RCHA)

[beer$$money]

RCHA COMPENSATION & DIVIDEND TO SHAREHOLDERS

RCHA 8K info:
This Support and Collaboration Agreement (the “Agreement”) is effective as of July 11, 2017 ("Effective Date") by and between Rich Pharmaceuticals, Inc., a Nevada corporation (“Rich”), and Mega Bridge, Inc., a Nevada corporation, to be renamed “Hypgen” (“Hypgen”).

3.1 Cash Compensation. Upon execution of this Agreement, Hypgen shall pay to Rich the amount of $100,000.

3.2 Equity Compensation. Within ten (10) days after execution of this Agreement, Hypgen shall issue to Rich the amount of 15,000,000 shares of Hypgen Common Stock. Rich shall dividend a minimum of 5,000,000 shares of the Hypgen Common Stock to its shareholders at such time as Rich completes the necessary and required corporate and regulatory requirements in connection with the dividend.


IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date indicated above.

MEGA BRIDGE, INC.,
a Nevada corporation
RICH PHARMACEUTIALS, INC.,
a Nevada corporation

By: /s/ Dr. McCoy Moretz,
Dr. McCoy Moretz
Chief Executive Officer

By: /s/ Ben Chang,
Ben Chang
Chief Executive Officer